Provided by Tiger Trade Technology Pte. Ltd.

ACLARION, INC

7.17
+0.670010.31%
Post-market: 6.71-0.4600-6.42%17:08 EST
Volume:176.51K
Turnover:1.27M
Market Cap:4.81M
PE:-0.59
High:7.70
Open:7.08
Low:6.81
Close:6.50
52wk High:3,499.51
52wk Low:5.55
Shares:671.40K
Float Shares:671.30K
Volume Ratio:24.79
T/O Rate:26.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.1234
EPS(LYR):-8.8206
ROE:-97.72%
ROA:-52.37%
PB:0.39
PE(LYR):-0.81

Loading ...

Company Profile

Company Name:
ACLARION, INC
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
6
Office Location:
8181 Arista Place,Suite 100,Broomfield,Colorado,United States
Zip Code:
80021
Fax:
- -
Introduction:
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Directors

Name
Position
Brent Ness
Chief Executive Officer, President and Director
Jeff Thramann
Executive Chairman and Director
Amanda Williams
Director
David Neal
Director
Scott Breidbart
Director
Steve Deitsch
Director
William G. Wesemann
Director

Shareholders

Name
Position
Brent Ness
Chief Executive Officer, President and Director
Gregory A. Gould
Chief Financial Officer
Jeff Thramann
Executive Chairman and Director
Ryan Bond
Chief Strategy Officer